Journal of Clinical and Cellular Immunology

Journal of Clinical and Cellular Immunology
Open Access

ISSN: 2155-9899

Journal of Clinical and Cellular Immunology : Citations & Metrics Report

Articles published in Journal of Clinical and Cellular Immunology have been cited by esteemed scholars and scientists all around the world. Journal of Clinical and Cellular Immunology has got h-index 42, which means every article in Journal of Clinical and Cellular Immunology has got 42 average citations.

Following are the list of articles that have cited the articles published in Journal of Clinical and Cellular Immunology.

  2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010

Total published articles

30 31 30 59 28 11 35 56 95 105 101 105 64 15 3

Research, Review articles and Editorials

2 13 8 23 18 8 25 35 54 86 79 35 23 14 3

Research communications, Review communications, Editorial communications, Case reports and Commentary

20 18 22 22 10 3 10 21 39 6 9 7 1 1 0

Conference proceedings

0 16 15 6 0 98 178 206 171 160 195 156 74 0 0

Citations received as per Google Scholar, other indexing platforms and portals

653 826 931 1079 1018 971 871 851 753 550 276 145 43 40 0
Journal total citations count 8361
Journal impact factor 24.12
Journal 5 years impact factor 31.14
Journal cite score 30.45
Journal h-index 42
Journal h-index since 2019 32
Important citations (1511)

sotiropoulos p (2015) study lemfangeiogenetikon agents and indicators carcinoma of the cervix. doctoral dissertation, university of patras.

rahul j (2015) significance of angiogenesis in both survival and extermination (via treatment) of the tumour. research and reviews: journal of pharmaceutics and nanotechnology.

hancock dg (2014) role of lymphatics in immunity-introduction. j clin cell immunol 5: e116.

yasala ak, khan t (2016) kdr/vegfr-2 receptor tyrosine kinase inhibitors and 3d qsar (comfa and comsia) study. research & reviews: journal of medical and health sciences 5: 1-7.

hancock dg (2014) role of lymphatics in immunity-introduction. j clin cell immunol 5: e116.

urbanski m, holfeld k, milne a, abbas m (2016) schnitzler syndrome without a monoclonal gammopathy: a case report. j cutan med surg 20: 575-578.

mirza n, prokop l, kowalewski d, gouttefangeas c, faul c, et al. (2016) soluble heat shock protein 70 members in patients undergoing allogeneic hematopoietic cell transplantation. transplant immunol 36: 25-31.

gunther s, ostheimer c2, stangl s, specht hm, mozes p, et al. (2015) correlation of hsp70 serum levels with gross tumor volume and composition of lymphocyte subpopulations in patients with squamous cell and adeno non-small cell lung cancer. front immunol 6: 556.

gunther s, ostheimer c, stangl s, specht hm, mozes p, et al. (2015) correlation of hsp70 serum levels with gross tumor volume and composition of lymphocyte subpopulations in patients with squamous cell and adeno non-small cell lung cancer. front immunol 6: 556.

werthmöller n, frey b, rückert m, lotter m, fietkau r, et al. (2016) combination of ionising radiation with hyperthermia increases the immunogenic potential of b16-f10 melanoma cells in vitro and in vivo. int j hyperthermia 32: 23-30.

multhoff g, habl g, combs se (2016) rationale of hyperthermia for radio (chemo) therapy and immune responses in patients with bladder cancer: biological concepts, clinical data, interdisciplinary treatment decisions and biological tumour imaging. int j hyperthermia 32: 455-463.

combs se, schmid te, vaupel p, multhoff g (2016) stress response leading to resistance in glioblastoma-the need for innovative radiotherapy (irt) concepts. cancers (basel).

gotanda k, hirota t, saito j, fukae m, egashira y, et al. (2016) circulating intestine-derived exosomal mir-328 in plasma, a possible biomarker for estimating bcrp function in the human intestines. sci rep.

hirota t, tanaka t, takesue h, ieiri i (2017) epigenetic regulation of drug transporter expression in human tissues. expert opin drug metabol toxicol 13: 19-30.

schwarzer j, multhoff g (2015) commentary to: ‘a comparison of two commercially available elisa methods for the quantification of human plasma heat shock protein 70 during rest and exercise stress’ by lee et al. 2015. cell stress chaperones 20: 865.

gunther s, ostheimer c, stangl s, specht hm, mozes p, et al. (2014) correlation of hsp70 serum levels with gross tumor volume and composition of lymphocyte subpopulations in patients with squamous cell and adeno non-small cell lung cancer. fron immunol 6: 556.

shevtsov m multhoff g (2016) heat shock protein-peptide and hsp-based immunotherapies for the treatment of cancer. front immunol 7: 171.

muth c, rubner y, semrau s, rühle pf, frey ib, et al. (2016) primary glioblastoma multiforme tumors and recurrence. strahlentherapie und onkologie 192: 146-155.

specht hm, ahrens n, blankenstein c, duell t, fietkau r, et al. (2015) heat shock protein 70 (hsp70) peptide activated natural killer (nk) cells for the treatment of patients with non-small cell lung cancer (nsclc) after radiochemotherapy (rctx)–from preclinical studies to a clinical phase ii trial. front immunol 6: 162.

radons j (2016) the human hsp70 family of chaperones: where do we stand? cell stress chaperones 21: 379-404.

Top